|
|
|
 |
|
 |
 |
|||
Company News
|
New anti-infectives company - Novexel - spun-out of the Sanofi-Aventis Group with €40M funding from Atlas-led VC group
Paris, France, 03 December 2004
top
Inpharmatica successfully closes GBP13.9M (USD25M) third round financing
London, UK, 08 November 2004
top
Solexa Announces Successful Closure of $14.4m financing
Cambridge, UK, 28 September 2004
top
Chroma Therapeutics Ltd completes £10M Series B Financing and appoints Peter Allen and Petri Vainio as non-executive Directors
Oxford, UK, 14 June 2004
top
Dynogen secures $50 million Series B financing to advance its pipeline of genitourinary and gastrointestinal development program
Boston, MA, 19 April 2004
top
Abingworth appoints Sarah Shackelton
London, UK, 15 April 2004
top
Ablynx Closes €25 Million Series B Financing
Funds Support Continued Development of Ablynx's Novel Antibody Drug Candidates
Ghent, Belgium, 06 April 2004
top
Abingworth appoints Genghis Lloyd-Harris
London, UK, 31 March 2004
top
Abingworth wins Private Equity Awards
London, UK, 31 March 2004
top
Abingworth appoints Michelle Doig
London, UK, 17 February 2004
top
Abingworth appoints Joe Anderson to manage quoted life science investments
London, UK, 10 February 2004
top
Hydra Biosciences Raises $18.875 Million in Series B Financing
Nick Colangelo of Lilly BioVentures appointed to Hydra's Board of Directors
Cambridge, MA, 12 January 2004
top
|
Archive:
|
|||||||||||||||||||||||||||||||||
2010